Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ecrins Therapeutics

Ecrins Therapeutics?uq=AFYHfsyn
2010 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
1 INVESTORS
Description

Owner and operator of a biotechnology company. The company is focused in the discovery and development of novel anti-cancer compounds and provides a range of biotechnological products.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Delivery
Primary Office
  • BioPolis
  • 5 avenue du Grand Sablon
  • 38700 La Tronche
  • France
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ecrins Therapeutics’s full profile, request a free trial.

Ecrins Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 04-Jul-2014 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Ecrins Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
GATE1 Accelerator/Incubator 000 0000 000000 0

Ecrins Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
Andreï Popov Ph.D Co-Founder, President & Chief Executive Officer
Aurélie Juhem Ph.D Co-Founder & Director of Research & Development
Francois Berger Ph.D Co-Founder